Chapter/Section Purchase

1 Study Coverage
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
2.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022)
2.4.2 Global Sales Gastrointestinal Stromal Tumor (GIST) Drug by Region (2023-2028)
2.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region
2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022)
2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers
3.1.1 Global Top Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2021
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Sales by Type (2017-2022)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2028)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2028)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type
4.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2022)
4.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Sales by Application (2017-2022)
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2028)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application
5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2028)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application
5.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2022)
5.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
6.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
6.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
6.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
6.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
6.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
6.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
7.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
7.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
7.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
7.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
8.1.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
8.2.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
8.3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
9.1.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
9.1.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
9.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
9.2.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
9.2.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
9.3 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
9.3.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
9.3.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
10.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
10.2.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
10.3.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ariad Pharmaceuticals, Inc.
11.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
11.1.2 Ariad Pharmaceuticals, Inc. Overview
11.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ariad Pharmaceuticals, Inc. Recent Developments
11.2 Arog Pharmaceuticals, Inc.
11.2.1 Arog Pharmaceuticals, Inc. Corporation Information
11.2.2 Arog Pharmaceuticals, Inc. Overview
11.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Arog Pharmaceuticals, Inc. Recent Developments
11.3 Array BioPharma Inc.
11.3.1 Array BioPharma Inc. Corporation Information
11.3.2 Array BioPharma Inc. Overview
11.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Array BioPharma Inc. Recent Developments
11.4 Astex Pharmaceuticals, Inc.
11.4.1 Astex Pharmaceuticals, Inc. Corporation Information
11.4.2 Astex Pharmaceuticals, Inc. Overview
11.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astex Pharmaceuticals, Inc. Recent Developments
11.5 Blueprint Medicines Corporation
11.5.1 Blueprint Medicines Corporation Corporation Information
11.5.2 Blueprint Medicines Corporation Overview
11.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Blueprint Medicines Corporation Recent Developments
11.6 Boston Biomedical, Inc.
11.6.1 Boston Biomedical, Inc. Corporation Information
11.6.2 Boston Biomedical, Inc. Overview
11.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boston Biomedical, Inc. Recent Developments
11.7 Calithera Biosciences, Inc.
11.7.1 Calithera Biosciences, Inc. Corporation Information
11.7.2 Calithera Biosciences, Inc. Overview
11.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Calithera Biosciences, Inc. Recent Developments
11.8 Chipscreen Biosciences Ltd
11.8.1 Chipscreen Biosciences Ltd Corporation Information
11.8.2 Chipscreen Biosciences Ltd Overview
11.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chipscreen Biosciences Ltd Recent Developments
11.9 Deciphera Pharmaceuticals, LLC
11.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
11.9.2 Deciphera Pharmaceuticals, LLC Overview
11.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.10.2 F. Hoffmann-La Roche Ltd. Overview
11.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.11 Horizon Pharma Plc
11.11.1 Horizon Pharma Plc Corporation Information
11.11.2 Horizon Pharma Plc Overview
11.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Horizon Pharma Plc Recent Developments
11.12 Immunicum AB
11.12.1 Immunicum AB Corporation Information
11.12.2 Immunicum AB Overview
11.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Immunicum AB Recent Developments
11.13 Jiangsu Hengrui Medicine Co., Ltd.
11.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
11.13.2 Jiangsu Hengrui Medicine Co., Ltd. Overview
11.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
11.14 Kolltan Pharmaceuticals, Inc.
11.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
11.14.2 Kolltan Pharmaceuticals, Inc. Overview
11.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
11.15 Natco Pharma Limited
11.15.1 Natco Pharma Limited Corporation Information
11.15.2 Natco Pharma Limited Overview
11.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Natco Pharma Limited Recent Developments
11.16 Nerviano Medical Sciences S.r.l.
11.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
11.16.2 Nerviano Medical Sciences S.r.l. Overview
11.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
11.17 Novartis AG
11.17.1 Novartis AG Corporation Information
11.17.2 Novartis AG Overview
11.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Novartis AG Recent Developments
11.18 Omeros Corporation
11.18.1 Omeros Corporation Corporation Information
11.18.2 Omeros Corporation Overview
11.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Omeros Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
12.4 Gastrointestinal Stromal Tumor (GIST) Drug Sales and Marketing
12.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
12.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
12.5 Gastrointestinal Stromal Tumor (GIST) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
13.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
13.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
13.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
14 Key Findings in The Global Gastrointestinal Stromal Tumor (GIST) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer